Galdakao-Usansolo University Hospital | Spain
María Riaza Montes is a dedicated Spanish urologist whose clinical and academic journey reflects a strong commitment to excellence in urological care, research, and medical education. She currently serves as an Assistant Urologist at Galdakao-Usansolo University Hospital and Quirónsalud Bizkaia Hospital, while also contributing her expertise to the field of andrology through her work with ANDROMEDI. Her professional focus spans advanced diagnostic and therapeutic approaches across the breadth of urologic and uro-oncologic conditions. Dr. Riaza Montes completed her medical degree at the University of Navarra, followed by an exceptional Urology Residency (MIR) at Galdakao University Hospital, where she graduated with an outstanding score of 9.85. Her academic portfolio is further distinguished by a comprehensive suite of specialized qualifications from CEU San Pablo University, including a Master’s Degree in Uro-oncology and multiple University Expert Titles covering renal, adrenal, retroperitoneal, prostate, testicular, penile, and urothelial cancers. These programs provided her with advanced training in diagnosis, treatment planning, and long-term follow-up of complex oncological pathologies, reflecting her profound interest in precision urologic oncology. In addition to her clinical and academic achievements, she has earned the FEBU certification in 2024, underscoring her adherence to European standards of urological competence. Her growing leadership in medical education is demonstrated through her role in resident supervision and her service as a tutor for medical students at the University of Deusto. She also contributes as an instructor in the Update Course in Urology organized by UPV/EHU, supporting the next generation of urologists through practical skills training.
Profile: Orcid
Featured Publications
Riaza Montes, M., Suárez, B., Solano-Iturri, J. D., Lecumberri, D., Iturregui, A. M., Lawrie, C. H., Armesto, M., Nunes-Xavier, C. E., Pulido, R., López, J. I., et al. (2025). Fibroblast activation protein alpha (FAP) expression is associated with disease recurrence and poor response to tyrosine kinase inhibitors in advanced clear cell renal cell carcinoma. International Journal of Molecular Sciences, 26(22), Article 11112.
Riaza Montes, M. (2025). Spatial profiling of fibroblast activation protein-α (FAP) in clear cell renal cell carcinomas using multiplex immunoanalysis of the tumor microenvironment. Société Internationale d’Urologie Journal, 6(5), Article 0067.
Kaufmann, E., Antonelli, L., Afferi, L., Asero, V., Prata, F., Rebuffo, S., Veccia, A., Culpan, M., Tully, K., Ribeiro, L., et al. (2025). Prevalence and prognostic significance of preoperative anemia in radical cystectomy patients: A multicenter retrospective observational study. European Urology Open Science, 74, Article 05.002.
Riaza Montes, M. (2025). Spatial profiling of fibroblast activation protein-α (FAP) in clear cell renal cell carcinomas using multiplex immunoanalysis of the tumor microenvironment. European Urology, 83(Supplement), Article 00085-5.
Riaza Montes, M. (2024). Malignant peripheral nerve sheath tumor in urethral caruncle. In Abstracts of the 44th Congress of the Société Internationale d’Urologie. Société Internationale d’Urologie Journal, 5(5), Article 0058.